SPC 3042

an antisense 16-mer locked nucleic acid gapmer and proapoptotic survivin inhibitor; base sequence in first source

Also Known As:

SPC-3042; SPC3042

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Fisker, Niels: 1 article (09/2008)
2.	Hansen, Henrik Frydenlund: 1 article (09/2008)
3.	Hansen, Jens Bo: 1 article (09/2008)
4.	Kjaerulff, Lene Sønderby: 1 article (09/2008)
5.	Koch, Troels: 1 article (09/2008)
6.	Orum, Henrik: 1 article (09/2008)
7.	Rosenbohm, Christoph: 1 article (09/2008)
8.	Thrue, Charlotte Albaek: 1 article (09/2008)
9.	Westergaard, Majken: 1 article (09/2008)
10.	Wissenbach, Margit: 1 article (09/2008)

1.	Prostatic Neoplasms (Prostate Cancer) 09/01/2008 - "It is also shown that SPC3042 is a sensitizer of prostate cancer cells to Taxol treatment in vitro and in vivo."

1.	Paclitaxel (Taxol)